Depression and Anxiety Trial, Recruiting NCT05699226 Sponsor: University of New Mexico Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT05699226
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with major depressive disorder or bipolar II disorder
  • People for whom doctors have determined that ECT (electroconvulsive therapy) using a specific electrode placement on the right side of the head is an appropriate treatment

Who may not be able to join:

  • People who have a diagnosed neurological or brain-related condition, such as a traumatic brain injury, epilepsy, or Alzheimer's disease
  • People who have certain other psychiatric conditions, such as schizophrenia or bipolar I disorder
  • People who currently have a drug or alcohol use disorder (note: nicotine use does not apply to this exclusion)
  • People who have any medical reason that would make having an MRI scan unsafe or unsuitable for them (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chris Abbott, MD, University of New Mexico

Phone: 5052720406

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of New Mexico
Registry
ClinicalTrials.gov
Start date
14 September 2023
Est. completion
1 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Inventory of Depressive Symptomatology - Clinician Rated; Delis Kaplan Executive Function System Letter Fluency

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov